Lacosamide

Details

Files
Generic Name:
Lacosamide
Project Status:
Complete
Therapeutic Area:
Epilepsy, partial onset seizures
Manufacturer:
UCB Canada Inc.
Call for patient/clinician input open:
Brand Name:
Vimpat
Project Line:
Reimbursement Review
Project Number:
SR0212-000
Call for patient/clinician input closed:
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Epilepsy, partial onset seizures (POS)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: